Microdosing and Workplace Performance: A Self-Report Case

The subject, a 37-year-old software engineer, self-administered psilocybin microdoses (0.15g dried mushrooms, 3×/week) over 12 weeks, maintaining a structured journal of mood, focus, creativity, and work output. This case study analyzes the journal data and 6-month follow-up.

Quantitative self-report data showed modest improvements in mood (PHQ-9: 8 → 4) and subjective focus (self-rated 6/10 → 7.5/10). Work output (measured by self-reported task completion and peer review) showed no significant change. The most notable finding was qualitative: the subject reported a shift in relationship to work — from anxiety-driven productivity to what he described as 'curiosity-driven engagement.' He reported less reactivity to setbacks and greater capacity to hold ambiguity.

At 6-month follow-up (after discontinuing microdosing), the mood improvements were partially maintained (PHQ-9: 6), but the shift in work relationship was fully maintained. The subject attributed the lasting change not to the substance but to the 'ritual of paying attention' that the dosing protocol enforced: 'The microdose was a reason to check in with myself three times a week. I think the checking in was the thing, not the drug.' This self-interpretation is consistent with the expectancy-effect hypothesis and raises the question of whether the ritual of intentional self-monitoring is the active ingredient in many self-administered protocols.